Keyphrases
Actionable Alteration
20%
Algorithmic Analysis
20%
Blood Biomarkers
20%
Chromogranin A
60%
Clinical Evaluation
20%
Clinical Protocols
20%
Clinical Status
20%
Disease Activity
20%
Disease Prediction
20%
Disease Progression
60%
Early Identification
20%
Early Prediction
20%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
80%
Image-based
20%
Imaging Biomarkers
20%
Indolence
20%
Longitudinal Imaging
20%
Multi-analyte
20%
NETest
100%
Preclinical Imaging
20%
Predicting Diseases
20%
Predictive Marker
20%
Predictive Utility
20%
Prognostic Marker
20%
Prognostic Utility
20%
Quantitative PCR
20%
Radioimmunoassay
20%
RECIST 1.1
20%
Rubicon
100%
Stable Disease
100%
Transcriptome Analysis
100%
Tumor Grade
20%
Well-differentiated
20%
Medicine and Dentistry
Biological Marker
25%
Chromogranin A
75%
Clinical Imaging
25%
Clinical Trial
25%
Disease Activity
25%
Disease Exacerbation
75%
Diseases
100%
Gastroenteropancreatic Neuroendocrine Tumor
100%
Neoplasm
25%
Radioimmunoassay
25%
Real-Time Polymerase Chain Reaction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
25%
Chromogranin A
75%
Clinical Trial
25%
Disease Activity
25%
Disease Exacerbation
75%
Diseases
100%
Gastroenteropancreatic Neuroendocrine Tumor
100%
Neoplasm
25%
Radioimmunoassay
25%
Biochemistry, Genetics and Molecular Biology
Chromogranin A
100%
Clinical Trial
33%
Real-Time Polymerase Chain Reaction
33%